Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-07-09FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Effects of Diet on Reflux and Dyspepsia
The study evaluating the effects of diet on symptoms of gastroesophageal reflux disease and dyspepsia has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) [Phase 3]
Phase 3 randomized trial comparing rabeprazole extended-release 50 mg with esomeprazole 40 mg for healing and symptom relief in moderate-to-…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) [Phase 3]
Phase 3 head-to-head trial comparing Rabeprazole Extended-Release 50 mg with Esomeprazole 40 mg for healing and symptomatic relief in modera…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD) [Phase 3]
Phase 3 trial comparing extended-release rabeprazole 50 mg to esomeprazole 40 mg for healing and symptomatic relief in mild-to-moderate eros…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD) [Phase 3]
Phase 3 trial comparing rabeprazole extended-release 50 mg to ranitidine 150 mg for maintenance of healed erosive GERD; results completed wi…
-
FDA approval · 2015-06-22FDA Approved: PRILOSEC OTC — Supplemental Application (The Procter & Gamble Manufacturing Company)
The FDA approved a supplemental application for Prilosec OTC (omeprazole magnesium) submitted by The Procter & Gamble Manufacturing Company.
-
CLINICAL_TRIALS research · 2015-06-22Clinical Trial Update: An Assessment of pH Testing Methods [NA]
A completed clinical trial from the University of Calgary evaluating pH testing methods for gastroesophageal reflux disease.
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD) [NA]
A clinical trial evaluating rubber band ligation and mucosectomy for gastroesophageal reflux disease was terminated.
-
CLINICAL_TRIALS withdrawal · 2015-06-19Clinical Trial Update: Nasopharyngeal 24 Hour pH Monitoring in Health Adult Volunteers [NA]
The clinical trial investigating nasopharyngeal 24-hour pH monitoring in healthy adult volunteers for gastroesophageal reflux disease has be…
-
FDA approval · 2015-06-10FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)
The FDA approved Riley Consumer Care LLC's supplemental application for ZEGERID OTC (omeprazole and sodium bicarbonate). This action finaliz…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: The Efficacy of Neiguan (P6 Point) Acupressure in Patients With Gastroesophageal Reflux Disease (GERD) [NA]
This document outlines an update on a clinical trial assessing the efficacy of Neiguan (P6) acupressure for patients with gastroesophageal r…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
This clinical trial is evaluating microRNA expression in blood and cytology as a noninvasive approach to detect Barrett's Esophagus and asso…
-
FDA approval · 2015-06-01FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by AmerisourceBergen, allowing the …
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: Study of a Dietary Supplement for Reflux During Sleep [NA]
This clinical trial evaluates a dietary supplement for managing reflux during sleep in individuals with gastroesophageal reflux disease. The…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents [Phase 2]
Phase 2 study in adolescents evaluating the safety and efficacy of dexlansoprazole delayed-release capsules for healing erosive esophagitis,…
-
CLINICAL_TRIALS research · 2015-05-12Clinical Trial Update: Gastroesophageal Reflux During LMA in Control Ventilation (LMA, Laryngeal Mask Airway) [NA]
This is a clinical trial update on gastroesophageal reflux during the use of a laryngeal mask airway with controlled ventilation. The curren…
-
FDA approval · 2015-05-06FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) submitted by Kenvue Brands LLC. This action expands the …
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology
Temple University’s registry study investigating gastrointestinal diseases in African Americans has completed recruitment, with results post…
-
CLINICAL_TRIALS withdrawal · 2015-04-29Clinical Trial Update: Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplication (TIF) Using EsophyX for the Treatment of GERD [Phase 2]
Phase 2 trial evaluating Tailored Transoral Incisionless Fundoplication (TIF) using the EsophyX device for gastroesophageal reflux disease h…
-
CLINICAL_TRIALS trial_result · 2015-04-24Clinical Trial Update: Study on the Tolerance and Efficacy of a New Anti Regurgitation Formula [Phase 3]
A Phase 3 trial evaluating the tolerance and efficacy of a new anti-regurgitation formula for gastroesophageal reflux disease has completed.
-
FDA approval · 2015-04-20FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength (famotidine) filed by Kenvue Brands LLC to update the OTC product lab…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use
A completed clinical trial evaluating an electronic health record-based intervention to manage gastroesophageal reflux disease and reduce ch…
-
FDA approval · 2015-04-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved Sandoz Inc's supplemental application for omeprazole, a generic proton pump inhibitor.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Minimal Change Esophagitis by i-Scan Endoscopy in Dyspeptic Patients
A completed clinical trial from Prince of Songkla University evaluated minimal change esophagitis detected by i-Scan endoscopy in dyspeptic …